Miyoshi, Seigo <br/><br/>
Antitumor activity of MEK and PI3K inhibitors against malignant pleural             mesothelioma cells in vitro and in vivo.  [electronic resource] 

 -  International journal of oncology  Aug 2012 
 - 449-56 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1791-2423 
<br/><br/><label>Standard No.: </label>10.3892/ijo.2012.1462  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Butadienes--pharmacology<br/>Cell Proliferation--drug effects<br/>Chromones--pharmacology<br/>Drug Synergism<br/>G1 Phase Cell Cycle Checkpoints--drug effects<br/>Humans<br/>MAP Kinase Kinase Kinases--antagonists & inhibitors<br/>MAP Kinase Signaling System--drug effects<br/>Male<br/>Mesothelioma--drug therapy<br/>Mice<br/>Mice, SCID<br/>Morpholines--pharmacology<br/>Nitriles--pharmacology<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Pleural Neoplasms--drug therapy<br/>Tumor Burden--drug effects<br/>Tumor Cells, Cultured<br/>Xenograft Model Antitumor Assays